Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aquaporin-4 (AQP4) is a water channel protein primarily expressed in astrocytes of the central nervous system. It facilitates rapid, selective transport of water across cell membranes and plays a critical role in maintaining CNS water homeostasis, edema formation/resolution, potassium buffering, and cerebrospinal fluid circulation. AQP4 is targeted by autoantibodies in neuromyelitis optica spectrum disorder (NMOSD), leading to inflammatory demyelination. It is also implicated in brain edema following injury or stroke. Potential roles are being investigated for epilepsy, glial scarring, neurodegenerative diseases, and psychiatric disorders.
Blocks pathogenic antibody binding in NMOSD (aquaporumab)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aquaporin-4 (AQP4).